Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2004043339) SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2004/043339 International Application No.: PCT/US2003/015780
Publication Date: 27.05.2004 International Filing Date: 20.05.2003
Chapter 2 Demand Filed: 16.12.2003
IPC:
A61K 31/47 (2006.01) ,A61K 31/4709 (2006.01) ,A61P 31/12 (2006.01) ,C07D 401/12 (2006.01) ,C07K 5/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
4709
Non-condensed quinolines containing further heterocyclic rings
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
401
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02
containing two hetero rings
12
linked by a chain containing hetero atoms as chain links
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
5
Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
04
containing only normal peptide links
08
Tripeptides
Applicants:
BRISTOL-MYERS SQUIBB COMPANY [US/US]; P.O. Box 4000 Route 206 and Provinceline Road Princeton, NJ 08543-4000, US (AllExceptUS)
CAMPBELL, Jeffrey, Allen [US/US]; US (UsOnly)
D'ANDREA, Stanley, V. [US/US]; US (UsOnly)
GOOD, Andrew [US/US]; US (UsOnly)
LI, Jianqing [US/US]; US (UsOnly)
MCPHEE, Fiona [US/US]; US (UsOnly)
RIPKA, Amy [US/US]; US (UsOnly)
SCOLA, Paul, Michael [US/US]; US (UsOnly)
TU, Yong [US/US]; US (UsOnly)
Inventors:
CAMPBELL, Jeffrey, Allen; US
D'ANDREA, Stanley, V.; US
GOOD, Andrew; US
LI, Jianqing; US
MCPHEE, Fiona; US
RIPKA, Amy; US
SCOLA, Paul, Michael; US
TU, Yong; US
Agent:
VOLLES, Warren, K. ; Bristol-Myers Squibb Company P.O. Box 4000 Princeton, NJ 08543-4000, US
Priority Data:
60/382,14920.05.2002US
Title (EN) SUBSTITUTED CYCLOALKYL P1' HEPATITIS C VIRUS INHIBITORS
(FR) INHIBITEURS DU VIRUS DE L'HEPATITE C A BASE DE CYCLOALKYLE P1' SUBSTITUE
Abstract:
(EN) The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
(FR) La présente invention concerne des composés tripeptidiques, des compositions et des procédés destinés au traitement de l'infection par le virus de l'hépatite C (VHC). L'invention concerne plus particulièrement de nouveaux tripeptides analogues, des compositions contenant de tels analogues, et des procédés visant à l'utilisation de ces analogues pour le traitement de l'infection par VHC.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
IS7531NO20044895PL373374PLP.373374EP1505945JP2006501307
JP4271148AU2003301959